Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis
Open Access
- 1 June 1998
- journal article
- clinical trial
- Published by BMJ in Archives of Disease in Childhood
- Vol. 78 (6), 536-539
- https://doi.org/10.1136/adc.78.6.536
Abstract
OBJECTIVE To compare once daily with thrice daily tobramycin for treatment of Pseudomonas aeruginosainfection in patients with cystic fibrosis. DESIGN 22 patients with cystic fibrosis, mean (SD) age 11 (3.4) years (range 5.6–19.3), with pulmonary pseudomonas exacerbations were randomly assigned to receive a 14 day course of tobramycin (15 mg/kg/day) either in three infusions (group A) (n = 10) or a single daily infusion (group B) (n = 12), combined with ceftazidime (200 mg/kg/day as three intravenous injections). Efficacy was assessed by comparison of pulmonary, nutritional, and inflammatory indices on days 1 and 14. Cochlear and renal tolerance were assessed on days 1 and 14. Tobramycin concentration was measured in serum and sputum 1, 2, 3, 4, 8, and 24 hours after the start of the infusion. Analysis was by non-parametric Wilcoxon test. RESULTS Variables improving (p < 0.05) in both groups A and B were, respectively: weight/height (+4% and +3.1%), plasma prealbumin (+66 and +63 mg/l), forced vital capacity (FVC) (+14% and +11%), forced expiratory volume in one second (+15% and +14%), and forced expiratory flow between 25% and 75% of FVC (+13% and +21%). Improvement was not significantly different between groups. Renal and cochlear indices remained within the normal range. Serum peak concentration of tobramycin on day 1 was 13.2 (7.1) mg/l in group A and 42.5 (11.2) mg/l in group B (p < 0.001); serum trough was 1.1 (0.8) mg/l in group A and 0.3 (0.2) mg/l in group B (p < 0.01). Tobramycin concentrations in sputum were two to three times higher in group B than group A. CONCLUSIONS Once daily tobramycin combined with three injections of ceftazidime is safe and effective for the treatment of pseudomonas exacerbations in cystic fibrosis patients.Keywords
This publication has 21 references indexed in Scilit:
- Pharmacoklnetics of once-daily versus thrice daily tobramycin in cystic flbrosis patientsJournal of Antimicrobial Chemotherapy, 1996
- Home care in cystic fibrosis patientsEuropean Respiratory Journal, 1995
- Optimisation of Antibiotic Therapy in Cystic Fibrosis PatientsClinical Pharmacokinetics, 1993
- Home intravenous antibiotic treatment of patients with cystic fibrosisActa Paediatrica, 1992
- Inactivatin of metronidazole by Enterococcus faecalisJournal of Antimicrobial Chemotherapy, 1991
- Cystic fibrosis.Archives of Disease in Childhood, 1990
- Antibiotic therapy in cystic fibrosis: Evaluation of clinical trialsThe Journal of Pediatrics, 1986
- Management of acute pulmonary exacerbations in cystic fibrosis: A critical appraisalThe Journal of Pediatrics, 1985
- Disposition of tobramycin in patients with cystic fibrosis: A prospective controlled studyThe Journal of Pediatrics, 1984
- FREQUENT ANTIBIOTIC THERAPY IMPROVES SURVIVAL OF CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTIONActa Paediatrica, 1983